166 related articles for article (PubMed ID: 28281288)
1. Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
Xu YT; Shen MH; Jin AY; Li H; Zhu R
Int J Gynaecol Obstet; 2017 Jun; 137(3):246-252. PubMed ID: 28281288
[TBL] [Abstract][Full Text] [Related]
2. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
Reddy A; Suri S; Sargent IL; Redman CW; Muttukrishna S
PLoS One; 2009; 4(2):e4453. PubMed ID: 19412349
[TBL] [Abstract][Full Text] [Related]
3. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.
Perucci LO; Gomes KB; Freitas LG; Godoi LC; Alpoim PN; Pinheiro MB; Miranda AS; Teixeira AL; Dusse LM; Sousa LP
PLoS One; 2014; 9(5):e97632. PubMed ID: 24851923
[TBL] [Abstract][Full Text] [Related]
4. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
5. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
[TBL] [Abstract][Full Text] [Related]
6. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
8. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
10. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia.
Hennessy A; Orange S; Willis N; Painter DM; Child A; Horvath JS
Clin Exp Pharmacol Physiol; 2002 Nov; 29(11):968-71. PubMed ID: 12366387
[TBL] [Abstract][Full Text] [Related]
12. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia.
Casagrandi D; Bearfield C; Geary J; Redman CW; Muttukrishna S
Mol Hum Reprod; 2003 Apr; 9(4):199-203. PubMed ID: 12651901
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
14. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
15. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies.
Keelan JA; Taylor R; Schellenberg JC; Groome NP; Mitchell MD; North RA
Obstet Gynecol; 2002 Feb; 99(2):267-74. PubMed ID: 11814508
[TBL] [Abstract][Full Text] [Related]
16. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders.
D'Antona D; Reis FM; Benedetto C; Evans LW; Groome NP; de Kretser DM; Wallace EM; Petraglia F
J Endocrinol; 2000 Apr; 165(1):157-62. PubMed ID: 10750046
[TBL] [Abstract][Full Text] [Related]
17. Altered autophagy induction by sera from pregnant women with pre-eclampsia: a case-control study.
Kanninen TT; Jayaram A; Jaffe Lifshitz S; Witkin SS
BJOG; 2014 Jul; 121(8):958-64. PubMed ID: 24690242
[TBL] [Abstract][Full Text] [Related]
18. Activin A and inhibin A as possible endocrine markers for pre-eclampsia.
Muttukrishna S; Knight PG; Groome NP; Redman CW; Ledger WL
Lancet; 1997 May; 349(9061):1285-8. PubMed ID: 9142063
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
Ultrasound Obstet Gynecol; 2014 Oct; 44(4):402-10. PubMed ID: 24913462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
